Tonight, after a week of calls by activists, the Drug Enforcement Administration updated its Web site to reflect the American Medical Association’s recent call for a review of marijuana’s Schedule I status.

The update removed several references to the AMA, including: “the American Medical Association recommends that marijuana remain a Schedule I controlled substance,” and “the American Medical Association has rejected pleas to endorse marijuana as medicine.” These changes came just over a week after the AMA released its new position on marijuana.

When it comes to marijuana’s status as a Schedule I drug, there is now a battle between cops and doctors. The cops say it has no medical value, but the doctors — who one might think are in a position to know — either say it does or, at a minimum, want the government to review its stance. And again, medical marijuana advocates are left wondering why the cops have a say in this debate at all. It will be interesting to see how the DEA does characterize the AMA’s new position. MPP will let you know when they do.

Share/Bookmark

Last week’s announcement from the American Medical Association — calling for a federal review of marijuana’s legal status — has been well received in the media, reaching the pages of The Washington Post, LA Times, and other publications. One group that hasn’t got the message is the Drug Enforcement Administration. This is no surprise, as the DEA has been ignoring recommendations to research marijuana’s medical benefits for decades.

But this example is particularly egregious. On the DEA Web page “Exposing the Myth of Smoked Medical Marijuana,” the agency writes, “the American Medical Association recommends that marijuana remain a Schedule I controlled substance.” That statement directly contradicts the new policy that the AMA issued last week.

The DEA also has a contact page where you can call them out on this (likely) willful ignorance of recent news: http://www.justice.gov/dea/contactinfo.htm

Share/Bookmark

Big news: The American Medical Association adopted a new policy position today calling for the review of marijuana’s status as a Schedule I drug.

The revised policy “urges that marijuana’s status as a federal Schedule I controlled substance be reviewed with the goal of facilitating the conduct of clinical research and development of cannabinoid-based medicines, and alternate delivery methods.” While it goes on to explain that the AMA is not stating support for state medical marijuana laws, the new policy does fall in line with what is quickly becoming a universal understanding in American medicine: Marijuana has undeniable medical uses and federal law should reflect that reality.

The new policy marks a historic shift from the AMA’s previous position, which recommended that “marijuana be retained in Schedule I,” grouping marijuana with drugs such as heroin, LSD, and PCP that are deemed to have no accepted medical uses.

The AMA’s previous position was often cited by medical marijuana opponents as evidence that the drug’s medical efficacy was in question. This new policy will go a long way to convincing politicians and policy makers that the compassionate use of medical marijuana should not be blocked by outdated marijuana laws.

Share/Bookmark